Retrotope (United States)
Retrotope, Inc. is a drug development company advancing the idea that polyunsaturated fatty acids drugs fortified with heavy isotopes protect living cells by making bonds within the delicate molecules inside and around cells harder to break. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Retrotope (United States), United States, covering academic research published from 2010 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
80
Total Open
Publications
42
Total
Citations
5.6K
Open Access
Percentage
53%
Total
Publications
80
Total Open
Publications
42
Total
Citations
5.6K
Breakdown
Publisher Open
10%
Both
27%
Other Platform Open
14%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 55%
16
Hybrid 21%
6
No Guarantees 24%
7
Other Platform Open
Domain 78%
25
Institution 22%
7
Other Internet 22%
7
Preprint 9%
3
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 25 |
DOI | Other Internet | 7 |
University of Cambridge | Institution | 4 |
Research Square | Preprint | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
Belarusian State University | Institution | 2 |
University of Edinburgh | Institution | 1 |
University of Aberdeen | Institution | 1 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
Nanyang Technological University | Institution | 1 |